Terug
Dagbereik
€ 1,64
€ 1,67
52-Weeksbereik
€ 1,24
€ 3,34
Volume
12.000
50D / 200D Gem.
€ 1,92
/
€ 2,04
Vorige Slotkoers
€ 1,67
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,9 | 0,3 |
| P/B | 3,4 | 3,0 |
| ROE % | -27,7 | 3,7 |
| Net Margin % | -64,9 | 3,8 |
| Rev Growth 5Y % | 13,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,10
€ 0,09 – € 0,12
|
695,90M | 1 |
| FY2029 |
€ 0,04
€ 0,03 – € 0,05
|
534,02M | 1 |
| FY2028 |
-€ 0,02
-€ 0,02 – -€ 0,01
|
425,60M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | -€ 0,09 | -€ 0,10 | -9,2% |
| 2025-09-02 | -€ 0,10 | -€ 0,10 | +2,1% |
| 2025-03-04 | -€ 0,13 | -€ 0,10 | +20,3% |
| 2024-09-03 | -€ 0,10 | -€ 0,11 | -8,4% |
| 2024-06-10 | -€ 0,06 | -€ 0,13 | -103,0% |
| 2023-06-30 | -€ 0,09 | -€ 0,11 | -20,8% |
| 2022-12-31 | -€ 0,07 | -€ 0,09 | -25,0% |
| 2022-06-30 | -€ 0,10 | -€ 0,04 | +54,3% |
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 13,76% annually over 5 years — strong growth
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -66,29M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8,44%
Capital efficient — spends only 1,56% of revenue on capex
Groei
Revenue Growth (5Y)
13,76%
Revenue (1Y)22,20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-27,66%
ROIC-23,07%
Net Margin-64,85%
Op. Margin-69,36%
Veiligheid
Debt / Equity
0,09
Current Ratio3,56
Interest Coverage-55,46
Waardering
P/E Ratio
-10,92
Forward P/EN/A
P/B Ratio3,42
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22,20% | Revenue Growth (3Y) | 14,87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13,76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 223,86M | Net Income (TTM) | -145,18M |
| ROE | -27,66% | ROA | -23,33% |
| Gross Margin | 58,64% | Operating Margin | -69,36% |
| Net Margin | -64,85% | Free Cash Flow (TTM) | -66,29M |
| ROIC | -23,07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 3,56 |
| Interest Coverage | -55,46 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10,92 | Forward P/E | N/A |
| P/B Ratio | 3,42 | P/S Ratio | 7,08 |
| PEG Ratio | 1,35 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -4,18% | ||
| Market Cap | 1,59B | Enterprise Value | 1,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 223,86M | 183,19M | 169,67M | 198,60M | 133,66M |
| Net Income | -145,18M | -146,19M | -154,51M | -91,03M | -167,61M |
| EPS (Diluted) | -0,15 | -0,16 | -0,19 | -0,11 | -0,20 |
| Gross Profit | 131,28M | 105,40M | 90,48M | 123,81M | 73,20M |
| Operating Income | -155,27M | -152,33M | -168,61M | -98,48M | -164,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 622,40M | 742,05M | 777,06M | 823,89M | 841,87M |
| Total Liabilities | 159,17M | 155,71M | 133,21M | 130,33M | 137,89M |
| Shareholders' Equity | 463,22M | 586,34M | 643,85M | 693,56M | 703,98M |
| Total Debt | 41,49M | 45,96M | 41,66M | 34,10M | 24,80M |
| Cash & Equivalents | 181,07M | 199,52M | 220,54M | 356,78M | 487,84M |
| Current Assets | 419,93M | 520,10M | 447,18M | 638,00M | 750,61M |
| Current Liabilities | 117,98M | 111,49M | 89,20M | 91,54M | 105,05M |